BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 22465636)

  • 1. Steroidal C-21 heteroaryl thioethers. Part 3: pregn-4-eno-[3,2-c]pyrazole fused A ring modified steroids as selective glucocorticoid receptor modulators (dissociated steroids).
    Biju P; Wang H; Anthes J; McCormick K; Aslanian R; Berlin M; Bitar R; Lim YH; Lee YJ; Prelusky D; Mcleod R; Jia Y; Fernandez X; Lieber G; Jimenez J; Eckel S; House A; Chapman R; Phillips J
    Bioorg Med Chem Lett; 2012 May; 22(9):3291-5. PubMed ID: 22465636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steroidal C-21 heteroaryl thioethers (Part 2): discovery of orally bioavailable selective glucocorticoid receptor modulators (dissociated steroids).
    Biju P; McCormick K; Aslanian R; Berlin M; Solomon D; Wang H; Lee YJ; Bitar R; Prelusky D; McLeod R; Jia Y; Fernandez X; Eckel S; House A; Lieber G; Jimenez J; Kelly G; Chapman R; Phillips J; Anthes J
    Bioorg Med Chem Lett; 2012 Jan; 22(2):1086-90. PubMed ID: 22197391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery and SAR of novel pyrazole-based thioethers as cathepsin S inhibitors. Part 2: Modification of P3, P4, and P5 regions.
    Wiener JJ; Wickboldt AT; Wiener DK; Lee-Dutra A; Edwards JP; Karlsson L; Nguyen S; Sun S; Jones TK; Grice CA
    Bioorg Med Chem Lett; 2010 Apr; 20(7):2375-8. PubMed ID: 20171097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery and SAR of novel pyrazole-based thioethers as cathepsin S inhibitors: part 1.
    Lee-Dutra A; Wiener DK; Arienti KL; Liu J; Mani N; Ameriks MK; Axe FU; Gebauer D; Desai PJ; Nguyen S; Randal M; Thurmond RL; Sun S; Karlsson L; Edwards JP; Jones TK; Grice CA
    Bioorg Med Chem Lett; 2010 Apr; 20(7):2370-4. PubMed ID: 20153648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonsteroidal dissociated glucocorticoid agonists containing azaindoles as steroid A-ring mimetics.
    Riether D; Harcken C; Razavi H; Kuzmich D; Gilmore T; Bentzien J; Pack EJ; Souza D; Nelson RM; Kukulka A; Fadra TN; Zuvela-Jelaska L; Pelletier J; Dinallo R; Panzenbeck M; Torcellini C; Nabozny GH; Thomson DS
    J Med Chem; 2010 Sep; 53(18):6681-98. PubMed ID: 20735001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel N-arylpyrazolo[3,2-c]-based ligands for the glucocorticoid receptor: receptor binding and in vivo activity.
    Ali A; Thompson CF; Balkovec JM; Graham DW; Hammond ML; Quraishi N; Tata JR; Einstein M; Ge L; Harris G; Kelly TM; Mazur P; Pandit S; Santoro J; Sitlani A; Wang C; Williamson J; Miller DK; Thompson CM; Zaller DM; Forrest MJ; Carballo-Jane E; Luell S
    J Med Chem; 2004 May; 47(10):2441-52. PubMed ID: 15115388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iodinated and fluorinated steroid 2'-aryl-[3,2-c] pyrazoles as potential glucocorticoid receptor imaging agents.
    Hoyte RM; Labaree DC; Fede JM; Harris C; Hochberg RB
    Steroids; 1998 Nov; 63(11):595-602. PubMed ID: 9830686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steroidal C-21 mercapto derivatives as dissociated steroids: discovery of an inhaled dissociated steroid.
    Biju P; McCormick K; Aslanian R; Berlin M; Solomon D; Chapman R; McLeod R; Prelusky D; Eckel S; Kelly G; Natiello M; House A; Fernandez X; Bitar R; Phillips J; Anthes J
    Bioorg Med Chem Lett; 2011 Nov; 21(21):6343-7. PubMed ID: 21944381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonsteroidal glucocorticoid agonists: tetrahydronaphthalenes with alternative steroidal A-ring mimetics possessing dissociated (transrepression/transactivation) efficacy selectivity.
    Biggadike K; Boudjelal M; Clackers M; Coe DM; Demaine DA; Hardy GW; Humphreys D; Inglis GG; Johnston MJ; Jones HT; House D; Loiseau R; Needham D; Skone PA; Uings I; Veitch G; Weingarten GG; McLay IM; Macdonald SJ
    J Med Chem; 2007 Dec; 50(26):6519-34. PubMed ID: 18038970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-steroidal glucocorticoid agonists: the discovery of aryl pyrazoles as A-ring mimetics.
    Clackers M; Coe DM; Demaine DA; Hardy GW; Humphreys D; Inglis GG; Johnston MJ; Jones HT; House D; Loiseau R; Minick DJ; Skone PA; Uings I; McLay IM; Macdonald SJ
    Bioorg Med Chem Lett; 2007 Sep; 17(17):4737-45. PubMed ID: 17616395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor density dictates the behavior of a subset of steroid ligands in glucocorticoid receptor-mediated transrepression.
    Zhao Q; Pang J; Favata MF; Trzaskos JM
    Int Immunopharmacol; 2003 Dec; 3(13-14):1803-17. PubMed ID: 14636830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thioether acetamides as P3 binding elements for tetrahydropyrido-pyrazole cathepsin S inhibitors.
    Wiener DK; Lee-Dutra A; Bembenek S; Nguyen S; Thurmond RL; Sun S; Karlsson L; Grice CA; Jones TK; Edwards JP
    Bioorg Med Chem Lett; 2010 Apr; 20(7):2379-82. PubMed ID: 20188543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel synthesis of the hexahydroimidazo[1,5b]isoquinoline scaffold: application to the synthesis of glucocorticoid receptor modulators.
    Xiao HY; Wu DR; Malley MF; Gougoutas JZ; Habte SF; Cunningham MD; Somerville JE; Dodd JH; Barrish JC; Nadler SG; Dhar TG
    J Med Chem; 2010 Feb; 53(3):1270-80. PubMed ID: 20047280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissociated nonsteroidal glucocorticoid receptor modulators; discovery of the agonist trigger in a tetrahydronaphthalene-benzoxazine series.
    Barker M; Clackers M; Copley R; Demaine DA; Humphreys D; Inglis GG; Johnston MJ; Jones HT; Haase MV; House D; Loiseau R; Nisbet L; Pacquet F; Skone PA; Shanahan SE; Tape D; Vinader VM; Washington M; Uings I; Upton R; McLay IM; Macdonald SJ
    J Med Chem; 2006 Jul; 49(14):4216-31. PubMed ID: 16821781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and evaluation of novel nonsteroidal dissociating glucocorticoid receptor ligands.
    Shah N; Scanlan TS
    Bioorg Med Chem Lett; 2004 Oct; 14(20):5199-203. PubMed ID: 15380227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel glucocorticoids containing a 6,5-bicyclic core fused to a pyrazole ring: synthesis, in vitro profile, molecular modeling studies, and in vivo experiments.
    Thompson CF; Quraishi N; Ali A; Mosley RT; Tata JR; Hammond ML; Balkovec JM; Einstein M; Ge L; Harris G; Kelly TM; Mazur P; Pandit S; Santoro J; Sitlani A; Wang C; Williamson J; Miller DK; Yamin TT; Thompson CM; O'Neill EA; Zaller D; Forrest MJ; Carballo-Jane E; Luell S
    Bioorg Med Chem Lett; 2007 Jun; 17(12):3354-61. PubMed ID: 17467988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The first X-ray crystal structure of the glucocorticoid receptor bound to a non-steroidal agonist.
    Madauss KP; Bledsoe RK; Mclay I; Stewart EL; Uings IJ; Weingarten G; Williams SP
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6097-9. PubMed ID: 18952422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microwave-enhanced nucleophilic fluorination in the synthesis of fluoropyridyl derivatives of [3,2-c]pyrazolo-corticosteroids, potential glucocorticoid receptor-mediated imaging agents.
    Kahn MG; Konde E; Dossou F; Labaree DC; Hochberg RB; Hoyte RM
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3454-8. PubMed ID: 16644222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterocyclic glucocorticoid receptor modulators with a 2,2-dimethyl-3-phenyl-N-(thiazol or thiadiazol-2-yl)propanamide core.
    Xiao HY; Wu DR; Sheppeck JE; Habte SF; Cunningham MD; Somerville JE; Barrish JC; Nadler SG; Dhar TG
    Bioorg Med Chem Lett; 2013 Oct; 23(20):5571-4. PubMed ID: 24011644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of dissociated non-steroidal glucocorticoid receptor agonists.
    Kuzmich D; Kirrane T; Proudfoot J; Bekkali Y; Zindell R; Beck L; Nelson R; Shih CK; Kukulka AJ; Paw Z; Reilly P; Deleon R; Cardozo M; Nabozny G; Thomson D
    Bioorg Med Chem Lett; 2007 Sep; 17(18):5025-31. PubMed ID: 17692519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.